220 related articles for article (PubMed ID: 31301676)
1. Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1.
Gopal-Kothandapani JS; Doshi AB; Smith K; Christian M; Mushtaq T; Banerjee I; Padidela R; Ramakrishnan R; Owen C; Cheetham T; Dimitri P
J Pediatr Endocrinol Metab; 2019 Sep; 32(9):959-967. PubMed ID: 31301676
[TBL] [Abstract][Full Text] [Related]
2. Novel mutations in the SCNN1A gene causing Pseudohypoaldosteronism type 1.
Wang J; Yu T; Yin L; Li J; Yu L; Shen Y; Yu Y; Shen Y; Fu Q
PLoS One; 2013; 8(6):e65676. PubMed ID: 23762408
[TBL] [Abstract][Full Text] [Related]
3. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.
Serra G; Antona V; D'Alessandro MM; Maggio MC; Verde V; Corsello G
Ital J Pediatr; 2021 Jun; 47(1):138. PubMed ID: 34134742
[TBL] [Abstract][Full Text] [Related]
4. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
Fernandes-Rosa FL; Antonini SR
Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular features of type 1 pseudohypoaldosteronism.
Riepe FG
Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
[TBL] [Abstract][Full Text] [Related]
6. Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1Aand SCNN1BGenes.
Cayir A; Demirelli Y; Yildiz D; Kahveci H; Yarali O; Kurnaz E; Vuralli D; Demirbilek H
Horm Res Paediatr; 2019; 91(3):175-185. PubMed ID: 31018202
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
[TBL] [Abstract][Full Text] [Related]
8. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
[TBL] [Abstract][Full Text] [Related]
9. Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1.
Welzel M; Akin L; Büscher A; Güran T; Hauffa BP; Högler W; Leonards J; Karges B; Kentrup H; Kirel B; Senses EE; Tekin N; Holterhus PM; Riepe FG
Eur J Endocrinol; 2013 May; 168(5):707-15. PubMed ID: 23416952
[TBL] [Abstract][Full Text] [Related]
10. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1.
Ekinci Z; Aytac MB; Cheong HI
J Pediatr Endocrinol Metab; 2013; 26(11-12):1197-200. PubMed ID: 23813355
[TBL] [Abstract][Full Text] [Related]
11. A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism Type 1.
Dogan CS; Erdem D; Mesut P; Merve A; Sema A; Iffet B; Afig B
J Pediatr Endocrinol Metab; 2012; 25(9-10):1035-9. PubMed ID: 23426840
[TBL] [Abstract][Full Text] [Related]
12. Pseudohypoaldosteronism.
Riepe FG
Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
[TBL] [Abstract][Full Text] [Related]
13. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
Riepe FG; Holterhus PM
Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
[TBL] [Abstract][Full Text] [Related]
14. A mild and transient form of autosomal recessive pseudohypoaldosteronism type 1 caused by a novel mutation in the
Efthymiadou A; Gautschi I; van Bemmelen MX; Sertedaki A; Giannakopoulos A; Chrousos G; Schild L; Chrysis D
Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E1-E9. PubMed ID: 37134141
[TBL] [Abstract][Full Text] [Related]
15. A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.
Dirlewanger M; Huser D; Zennaro MC; Girardin E; Schild L; Schwitzgebel VM
Am J Physiol Endocrinol Metab; 2011 Sep; 301(3):E467-73. PubMed ID: 21653223
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid resistance.
Zennaro MC; Lombès M
Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of naturally occurring NR3C2 gene mutations in Italian patients suffering from pseudohypoaldosteronism type 1.
Balsamo A; Cicognani A; Gennari M; Sippell WG; Menabò S; Baronio F; Riepe FG
Eur J Endocrinol; 2007 Feb; 156(2):249-56. PubMed ID: 17287415
[TBL] [Abstract][Full Text] [Related]
19. Pseudohypoaldosteronism in a newborn male with functional polymorphisms in the mineralocorticoid receptor genes.
Jeong HA; Park YK; Jung YS; Nam MH; Nam HK; Lee KH; Rhie YJ
Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):230-4. PubMed ID: 26817011
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
